Gene Symbol | Gene ID | Gene Info |
---|---|---|
Cux1
|
ENSMUSG00000029705.11 | cut-like homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_136568032_136568221 | Cux1 | 636 | 0.755415 | -0.47 | 1.3e-04 | Click! |
chr5_136568531_136568958 | Cux1 | 1254 | 0.506299 | -0.40 | 1.8e-03 | Click! |
chr5_136623622_136623825 | Cux1 | 56233 | 0.111368 | -0.32 | 1.2e-02 | Click! |
chr5_136581221_136582666 | Cux1 | 14453 | 0.208577 | -0.31 | 1.5e-02 | Click! |
chr5_136565730_136566466 | Cux1 | 253 | 0.933764 | 0.29 | 2.6e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_13835523_13837039 | 15.96 |
Gpr85 |
G protein-coupled receptor 85 |
960 |
0.59 |
chr18_25751839_25752425 | 13.45 |
Celf4 |
CUGBP, Elav-like family member 4 |
560 |
0.81 |
chr10_34299043_34301066 | 13.19 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr1_99772154_99773556 | 12.10 |
Cntnap5b |
contactin associated protein-like 5B |
90 |
0.98 |
chr5_130449887_130450187 | 12.07 |
Caln1 |
calneuron 1 |
1236 |
0.55 |
chr8_67817715_67818694 | 10.74 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
29 |
0.99 |
chr2_65620767_65621991 | 10.72 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
568 |
0.82 |
chr12_88725437_88725947 | 10.64 |
Nrxn3 |
neurexin III |
11 |
0.98 |
chr10_29148067_29148387 | 10.53 |
Soga3 |
SOGA family member 3 |
430 |
0.81 |
chrX_143930842_143933141 | 10.50 |
Dcx |
doublecortin |
1059 |
0.64 |
chr11_32001099_32002296 | 10.12 |
Nsg2 |
neuron specific gene family member 2 |
1195 |
0.52 |
chr3_88208985_88210116 | 9.51 |
Gm3764 |
predicted gene 3764 |
78 |
0.92 |
chr1_115684558_115685809 | 9.43 |
Cntnap5a |
contactin associated protein-like 5A |
427 |
0.58 |
chr5_112576144_112577196 | 8.55 |
Sez6l |
seizure related 6 homolog like |
198 |
0.92 |
chr14_66347306_66348516 | 8.54 |
Stmn4 |
stathmin-like 4 |
3530 |
0.22 |
chr12_72234504_72235243 | 8.52 |
Rtn1 |
reticulon 1 |
866 |
0.66 |
chr7_92234907_92236280 | 8.52 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr2_172040251_172043672 | 8.27 |
Cbln4 |
cerebellin 4 precursor protein |
1505 |
0.35 |
chr9_110051810_110053856 | 8.20 |
Map4 |
microtubule-associated protein 4 |
781 |
0.54 |
chr8_123891512_123893657 | 8.11 |
Acta1 |
actin, alpha 1, skeletal muscle |
2167 |
0.16 |
chr6_112943851_112944495 | 8.01 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
2581 |
0.19 |
chr10_57784547_57786586 | 8.01 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr7_140154045_140155011 | 7.88 |
Sprn |
shadow of prion protein |
349 |
0.75 |
chr1_50929921_50930145 | 7.79 |
Tmeff2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
2514 |
0.33 |
chr3_89092211_89093650 | 7.49 |
Rusc1 |
RUN and SH3 domain containing 1 |
360 |
0.7 |
chr8_31917541_31918367 | 7.36 |
Nrg1 |
neuregulin 1 |
288 |
0.81 |
chrX_88113433_88114223 | 7.23 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
1817 |
0.46 |
chr7_139833633_139836105 | 7.19 |
Adgra1 |
adhesion G protein-coupled receptor A1 |
93 |
0.96 |
chr9_75681964_75682559 | 7.16 |
Scg3 |
secretogranin III |
1326 |
0.37 |
chr8_84934277_84934726 | 7.13 |
Mast1 |
microtubule associated serine/threonine kinase 1 |
2843 |
0.09 |
chr2_158375202_158376961 | 7.10 |
Snhg11 |
small nucleolar RNA host gene 11 |
319 |
0.74 |
chr2_65847409_65848267 | 7.03 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
1983 |
0.36 |
chrX_136590440_136591154 | 6.99 |
Tceal3 |
transcription elongation factor A (SII)-like 3 |
45 |
0.96 |
chr9_112231189_112232055 | 6.86 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
280 |
0.9 |
chrX_6169933_6171264 | 6.81 |
Nudt10 |
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
2417 |
0.31 |
chr10_127532001_127533071 | 6.78 |
Nxph4 |
neurexophilin 4 |
2023 |
0.18 |
chr10_29143400_29144848 | 6.74 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr5_65132296_65132503 | 6.68 |
Klhl5 |
kelch-like 5 |
728 |
0.62 |
chr10_80300884_80302968 | 6.68 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
106 |
0.9 |
chr13_83737592_83739114 | 6.68 |
Gm33366 |
predicted gene, 33366 |
182 |
0.66 |
chr7_51623529_51624502 | 6.66 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
1133 |
0.51 |
chr13_20473087_20474265 | 6.62 |
Gm32036 |
predicted gene, 32036 |
186 |
0.89 |
chr4_109342938_109343450 | 6.61 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
59 |
0.97 |
chr14_39471112_39471496 | 6.59 |
Nrg3 |
neuregulin 3 |
1362 |
0.61 |
chr13_83724722_83725570 | 6.58 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2960 |
0.17 |
chr13_83719687_83720586 | 6.49 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1245 |
0.36 |
chr6_110645148_110646464 | 6.43 |
Gm20387 |
predicted gene 20387 |
110 |
0.67 |
chr9_112232067_112232798 | 6.40 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
69 |
0.97 |
chr2_29845262_29846623 | 6.37 |
Mir219a-2 |
microRNA 219a-2 |
215 |
0.56 |
chr14_93887180_93887734 | 6.32 |
Pcdh9 |
protocadherin 9 |
1233 |
0.6 |
chr14_64588312_64589438 | 6.32 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
341 |
0.81 |
chr13_83732205_83734272 | 6.30 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr19_6418703_6419936 | 6.26 |
Nrxn2 |
neurexin II |
554 |
0.44 |
chr2_34368351_34369364 | 6.24 |
Pbx3 |
pre B cell leukemia homeobox 3 |
1989 |
0.33 |
chr11_69211021_69211683 | 6.23 |
Alox8 |
arachidonate 8-lipoxygenase |
13509 |
0.1 |
chr9_108824114_108825614 | 6.20 |
Gm35025 |
predicted gene, 35025 |
3 |
0.87 |
chr1_42686011_42687379 | 6.19 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
6398 |
0.14 |
chr12_88725972_88726370 | 6.16 |
Nrxn3 |
neurexin III |
490 |
0.84 |
chr6_134886811_134888239 | 6.09 |
Gpr19 |
G protein-coupled receptor 19 |
243 |
0.87 |
chr16_81202167_81203211 | 6.03 |
Ncam2 |
neural cell adhesion molecule 2 |
1932 |
0.44 |
chr7_65154721_65155254 | 6.00 |
Fam189a1 |
family with sequence similarity 189, member A1 |
1429 |
0.4 |
chr2_24473566_24475385 | 5.97 |
Pax8 |
paired box 8 |
622 |
0.64 |
chr18_31316134_31317386 | 5.97 |
Rit2 |
Ras-like without CAAX 2 |
351 |
0.9 |
chr5_98182267_98183697 | 5.96 |
Prdm8 |
PR domain containing 8 |
2004 |
0.26 |
chr1_136132801_136134260 | 5.91 |
Kif21b |
kinesin family member 21B |
2076 |
0.19 |
chrX_170674573_170675954 | 5.85 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr14_84446582_84446935 | 5.83 |
Pcdh17 |
protocadherin 17 |
1749 |
0.43 |
chr8_61515455_61516269 | 5.70 |
Palld |
palladin, cytoskeletal associated protein |
38 |
0.98 |
chr3_117359414_117360458 | 5.69 |
Plppr4 |
phospholipid phosphatase related 4 |
312 |
0.92 |
chr5_116589538_116590511 | 5.68 |
Srrm4 |
serine/arginine repetitive matrix 4 |
1793 |
0.34 |
chr3_57846307_57846818 | 5.67 |
Pfn2 |
profilin 2 |
583 |
0.72 |
chr6_77245550_77245946 | 5.66 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
2826 |
0.35 |
chr4_33926104_33927188 | 5.65 |
Cnr1 |
cannabinoid receptor 1 (brain) |
444 |
0.88 |
chr7_87586513_87587584 | 5.65 |
Grm5 |
glutamate receptor, metabotropic 5 |
2650 |
0.4 |
chr13_69737356_69737994 | 5.59 |
Ube2ql1 |
ubiquitin-conjugating enzyme E2Q family-like 1 |
2214 |
0.21 |
chr8_22977325_22978617 | 5.57 |
Ank1 |
ankyrin 1, erythroid |
2835 |
0.24 |
chr14_93888035_93888426 | 5.54 |
Pcdh9 |
protocadherin 9 |
502 |
0.87 |
chr2_152083384_152083946 | 5.54 |
Scrt2 |
scratch family zinc finger 2 |
2136 |
0.23 |
chr3_73055286_73056050 | 5.54 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
1275 |
0.44 |
chr13_34125172_34126139 | 5.52 |
Tubb2b |
tubulin, beta 2B class IIB |
4699 |
0.12 |
chr10_110453550_110454045 | 5.52 |
Nav3 |
neuron navigator 3 |
2407 |
0.34 |
chr6_121472749_121474141 | 5.49 |
Iqsec3 |
IQ motif and Sec7 domain 3 |
178 |
0.95 |
chr1_79450112_79451070 | 5.40 |
Scg2 |
secretogranin II |
10471 |
0.24 |
chr3_17793835_17795104 | 5.39 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
427 |
0.75 |
chr8_12385818_12386491 | 5.38 |
Sox1ot |
Sox1 overlapping transcript |
383 |
0.8 |
chr16_13986350_13987796 | 5.38 |
Ifitm7 |
interferon induced transmembrane protein 7 |
185 |
0.71 |
chr4_110281444_110282224 | 5.37 |
Elavl4 |
ELAV like RNA binding protein 4 |
4782 |
0.33 |
chr13_8207058_8207829 | 5.35 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
4521 |
0.2 |
chr8_58912073_58913264 | 5.35 |
Galntl6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 |
28 |
0.88 |
chr15_91017138_91018295 | 5.34 |
Kif21a |
kinesin family member 21A |
32102 |
0.16 |
chr11_84520959_84524590 | 5.34 |
Lhx1 |
LIM homeobox protein 1 |
63 |
0.97 |
chr15_68931535_68932379 | 5.30 |
Khdrbs3 |
KH domain containing, RNA binding, signal transduction associated 3 |
1889 |
0.38 |
chr1_81077232_81078427 | 5.28 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr5_30711890_30712870 | 5.28 |
Dpysl5 |
dihydropyrimidinase-like 5 |
479 |
0.75 |
chr1_133735425_133736534 | 5.27 |
Mir6903 |
microRNA 6903 |
9334 |
0.14 |
chrX_58034447_58034953 | 5.25 |
Zic3 |
zinc finger protein of the cerebellum 3 |
3690 |
0.31 |
chrX_166347339_166348040 | 5.24 |
Gpm6b |
glycoprotein m6b |
2847 |
0.32 |
chr6_83185720_83187846 | 5.23 |
Dctn1 |
dynactin 1 |
837 |
0.39 |
chr10_80298461_80300404 | 5.22 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
341 |
0.69 |
chr19_6498687_6498960 | 5.15 |
Nrxn2 |
neurexin II |
988 |
0.42 |
chr5_111422795_111423499 | 5.14 |
Gm43119 |
predicted gene 43119 |
442 |
0.8 |
chr3_88831100_88832914 | 5.14 |
1500004A13Rik |
RIKEN cDNA 1500004A13 gene |
361 |
0.77 |
chr2_22624675_22625045 | 5.13 |
Gad2 |
glutamic acid decarboxylase 2 |
1556 |
0.29 |
chr5_135248496_135249658 | 5.11 |
Fzd9 |
frizzled class receptor 9 |
2153 |
0.21 |
chr2_65566312_65566743 | 5.09 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
965 |
0.63 |
chr18_60925301_60926809 | 5.09 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
330 |
0.84 |
chr11_41999400_42000640 | 5.06 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
336 |
0.92 |
chr9_91359026_91359334 | 5.05 |
Zic4 |
zinc finger protein of the cerebellum 4 |
3233 |
0.14 |
chr4_110284419_110284817 | 5.03 |
Elavl4 |
ELAV like RNA binding protein 4 |
1998 |
0.47 |
chr1_81079064_81079824 | 5.02 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
1861 |
0.49 |
chr12_53248556_53249180 | 5.02 |
Npas3 |
neuronal PAS domain protein 3 |
191 |
0.97 |
chr8_64691882_64692436 | 5.01 |
Cpe |
carboxypeptidase E |
895 |
0.57 |
chr6_77978407_77979215 | 5.01 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
739 |
0.71 |
chr14_64592977_64593388 | 5.00 |
Mir3078 |
microRNA 3078 |
1997 |
0.25 |
chr12_27064608_27065073 | 5.00 |
Gm9866 |
predicted gene 9866 |
50155 |
0.18 |
chr6_8950297_8950448 | 4.96 |
Nxph1 |
neurexophilin 1 |
696 |
0.81 |
chr15_25754845_25755428 | 4.96 |
Myo10 |
myosin X |
2157 |
0.37 |
chr2_65929929_65930575 | 4.94 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
115 |
0.97 |
chr2_25264308_25268001 | 4.94 |
Tprn |
taperin |
1410 |
0.14 |
chr5_112574293_112574972 | 4.92 |
Sez6l |
seizure related 6 homolog like |
2236 |
0.24 |
chr8_54956411_54956563 | 4.92 |
Gpm6a |
glycoprotein m6a |
1644 |
0.32 |
chr1_146494200_146495557 | 4.90 |
Gm29514 |
predicted gene 29514 |
73 |
0.56 |
chr18_25749825_25750329 | 4.89 |
Celf4 |
CUGBP, Elav-like family member 4 |
2615 |
0.33 |
chr18_64265796_64267074 | 4.88 |
St8sia3 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 |
47 |
0.97 |
chr13_83715222_83716973 | 4.86 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5284 |
0.15 |
chr5_121009225_121009749 | 4.86 |
Rph3a |
rabphilin 3A |
51 |
0.97 |
chr6_103510606_103512502 | 4.86 |
Chl1 |
cell adhesion molecule L1-like |
224 |
0.93 |
chr4_110285468_110287125 | 4.84 |
Elavl4 |
ELAV like RNA binding protein 4 |
320 |
0.94 |
chr4_42951254_42951979 | 4.84 |
Dnajb5 |
DnaJ heat shock protein family (Hsp40) member B5 |
1176 |
0.34 |
chr12_31710202_31710828 | 4.83 |
Gpr22 |
G protein-coupled receptor 22 |
3411 |
0.2 |
chr12_71049290_71050137 | 4.81 |
Arid4a |
AT rich interactive domain 4A (RBP1-like) |
1372 |
0.4 |
chr15_75565497_75565648 | 4.81 |
Ly6h |
lymphocyte antigen 6 complex, locus H |
1060 |
0.41 |
chr4_110282527_110283235 | 4.80 |
Elavl4 |
ELAV like RNA binding protein 4 |
3735 |
0.36 |
chr12_46816152_46816702 | 4.79 |
Nova1 |
NOVA alternative splicing regulator 1 |
533 |
0.8 |
chr8_54954519_54955779 | 4.79 |
Gpm6a |
glycoprotein m6a |
306 |
0.88 |
chr6_83171941_83172736 | 4.79 |
Gm15624 |
predicted gene 15624 |
216 |
0.83 |
chr9_41582824_41584205 | 4.74 |
Mir125b-1 |
microRNA 125b-1 |
1588 |
0.2 |
chr13_83736071_83736534 | 4.72 |
Gm33366 |
predicted gene, 33366 |
2233 |
0.18 |
chr17_73708321_73708687 | 4.71 |
Galnt14 |
polypeptide N-acetylgalactosaminyltransferase 14 |
1562 |
0.44 |
chr9_52148115_52149635 | 4.68 |
Zc3h12c |
zinc finger CCCH type containing 12C |
19236 |
0.18 |
chr10_18470218_18471289 | 4.68 |
Nhsl1 |
NHS-like 1 |
772 |
0.72 |
chr6_88872932_88873571 | 4.64 |
Podxl2 |
podocalyxin-like 2 |
794 |
0.47 |
chr6_13833304_13833848 | 4.64 |
Gpr85 |
G protein-coupled receptor 85 |
3665 |
0.25 |
chr11_84526864_84527823 | 4.64 |
Lhx1os |
LIM homeobox 1, opposite strand |
1659 |
0.31 |
chr1_42691569_42692627 | 4.61 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
995 |
0.42 |
chr2_113828248_113829427 | 4.60 |
Scg5 |
secretogranin V |
75 |
0.97 |
chr1_115686481_115687365 | 4.58 |
Cntnap5a |
contactin associated protein-like 5A |
2167 |
0.34 |
chr15_20448699_20449797 | 4.57 |
Cdh12 |
cadherin 12 |
17 |
0.53 |
chr7_24485614_24487418 | 4.57 |
Cadm4 |
cell adhesion molecule 4 |
4493 |
0.1 |
chr15_72806569_72807700 | 4.56 |
Peg13 |
paternally expressed 13 |
3190 |
0.32 |
chr2_181766837_181767244 | 4.56 |
Myt1 |
myelin transcription factor 1 |
2 |
0.97 |
chr3_45379351_45381850 | 4.56 |
Pcdh10 |
protocadherin 10 |
2033 |
0.25 |
chr5_107498136_107498752 | 4.55 |
Btbd8 |
BTB (POZ) domain containing 8 |
665 |
0.57 |
chr5_27262523_27263109 | 4.54 |
Dpp6 |
dipeptidylpeptidase 6 |
841 |
0.69 |
chr13_83717521_83718816 | 4.53 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3213 |
0.17 |
chr3_8513445_8513907 | 4.47 |
Stmn2 |
stathmin-like 2 |
4090 |
0.25 |
chr14_84446983_84448692 | 4.44 |
Pcdh17 |
protocadherin 17 |
670 |
0.76 |
chr14_79769346_79769801 | 4.44 |
Gm9748 |
predicted gene 9748 |
335 |
0.82 |
chr5_131534533_131535200 | 4.43 |
Auts2 |
autism susceptibility candidate 2 |
469 |
0.81 |
chr11_55605810_55606199 | 4.43 |
Glra1 |
glycine receptor, alpha 1 subunit |
1729 |
0.39 |
chr9_91363965_91365514 | 4.42 |
Zic1 |
zinc finger protein of the cerebellum 1 |
1029 |
0.35 |
chrX_169827749_169828991 | 4.41 |
Mid1 |
midline 1 |
211 |
0.96 |
chr7_44973695_44975193 | 4.41 |
Cpt1c |
carnitine palmitoyltransferase 1c |
331 |
0.61 |
chrX_69363262_69363944 | 4.38 |
Gm14705 |
predicted gene 14705 |
2334 |
0.33 |
chr1_50928853_50929386 | 4.37 |
Tmeff2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
1600 |
0.44 |
chr14_111676987_111677210 | 4.37 |
Slitrk5 |
SLIT and NTRK-like family, member 5 |
1249 |
0.5 |
chr18_43389837_43390467 | 4.36 |
Dpysl3 |
dihydropyrimidinase-like 3 |
3225 |
0.29 |
chr13_44842150_44842855 | 4.35 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
1719 |
0.39 |
chr6_77246252_77246852 | 4.33 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
3630 |
0.32 |
chr11_97572309_97572897 | 4.33 |
Srcin1 |
SRC kinase signaling inhibitor 1 |
1326 |
0.33 |
chr5_117841452_117842996 | 4.31 |
Nos1 |
nitric oxide synthase 1, neuronal |
38 |
0.98 |
chr10_111247804_111248910 | 4.31 |
Osbpl8 |
oxysterol binding protein-like 8 |
289 |
0.91 |
chr9_96729464_96730774 | 4.30 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
1083 |
0.47 |
chr2_65934036_65934599 | 4.30 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
2452 |
0.32 |
chr5_5264770_5266186 | 4.30 |
Cdk14 |
cyclin-dependent kinase 14 |
169 |
0.96 |
chr14_64574784_64575443 | 4.30 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
12218 |
0.15 |
chr2_53501543_53502209 | 4.29 |
Gm13503 |
predicted gene 13503 |
50050 |
0.17 |
chr7_62376325_62378263 | 4.28 |
Magel2 |
melanoma antigen, family L, 2 |
284 |
0.9 |
chr18_43686487_43688415 | 4.27 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr16_77537075_77537402 | 4.26 |
Gm36963 |
predicted gene, 36963 |
2644 |
0.18 |
chr8_47284401_47285223 | 4.26 |
Stox2 |
storkhead box 2 |
4550 |
0.27 |
chr14_108910678_108911967 | 4.26 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
2836 |
0.42 |
chr8_12398370_12398923 | 4.24 |
Gm25239 |
predicted gene, 25239 |
2243 |
0.21 |
chr17_91090702_91091377 | 4.24 |
Nrxn1 |
neurexin I |
1694 |
0.28 |
chr1_143641893_143642230 | 4.20 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
464 |
0.75 |
chr12_46814495_46815083 | 4.20 |
Nova1 |
NOVA alternative splicing regulator 1 |
2171 |
0.31 |
chr11_66524173_66524698 | 4.20 |
Shisa6 |
shisa family member 6 |
1360 |
0.55 |
chr8_4216103_4217573 | 4.19 |
Prr36 |
proline rich 36 |
74 |
0.93 |
chr2_22625054_22625976 | 4.17 |
Gad2 |
glutamic acid decarboxylase 2 |
2211 |
0.22 |
chr7_113673057_113673464 | 4.17 |
Gm23700 |
predicted gene, 23700 |
6244 |
0.2 |
chr16_32658952_32659852 | 4.14 |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
477 |
0.75 |
chr3_17792584_17792950 | 4.13 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1153 |
0.46 |
chr6_105676979_105678296 | 4.13 |
Cntn4 |
contactin 4 |
23 |
0.52 |
chr12_68996734_68997089 | 4.13 |
Gm47515 |
predicted gene, 47515 |
1941 |
0.32 |
chr15_25417534_25417691 | 4.12 |
Gm48957 |
predicted gene, 48957 |
2549 |
0.21 |
chr18_59062200_59063436 | 4.11 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
307 |
0.94 |
chr16_77596529_77597235 | 4.11 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
1980 |
0.16 |
chr10_11081408_11082323 | 4.10 |
Grm1 |
glutamate receptor, metabotropic 1 |
385 |
0.89 |
chr2_6883618_6884699 | 4.09 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr2_152085191_152085589 | 4.08 |
Scrt2 |
scratch family zinc finger 2 |
3861 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.6 | 10.7 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
3.2 | 16.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
3.2 | 9.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
3.0 | 33.2 | GO:0071625 | vocalization behavior(GO:0071625) |
2.9 | 14.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
2.8 | 5.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.6 | 7.9 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.5 | 7.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
2.5 | 14.8 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
2.5 | 22.1 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
2.4 | 4.8 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.3 | 16.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.3 | 6.9 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.2 | 19.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
2.2 | 11.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.2 | 4.4 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
2.1 | 6.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
2.0 | 8.1 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.0 | 6.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
2.0 | 6.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.0 | 6.0 | GO:0097503 | sialylation(GO:0097503) |
2.0 | 5.9 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
2.0 | 5.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.9 | 17.4 | GO:0060074 | synapse maturation(GO:0060074) |
1.9 | 3.9 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
1.9 | 3.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.9 | 1.9 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.9 | 7.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.8 | 5.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.8 | 9.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.8 | 8.9 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.8 | 5.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.8 | 14.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.8 | 7.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
1.7 | 7.0 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
1.7 | 3.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.7 | 1.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.7 | 5.0 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.7 | 13.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.7 | 8.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.6 | 13.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.6 | 4.8 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.6 | 3.2 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
1.5 | 37.1 | GO:0001964 | startle response(GO:0001964) |
1.5 | 12.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.5 | 3.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.5 | 4.4 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
1.4 | 8.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.4 | 4.3 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.4 | 5.7 | GO:0060174 | limb bud formation(GO:0060174) |
1.4 | 6.9 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.4 | 4.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.4 | 4.1 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.4 | 2.7 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
1.4 | 2.7 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.4 | 8.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.3 | 12.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.3 | 7.8 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.3 | 1.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.3 | 5.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.3 | 5.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.3 | 3.8 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.2 | 8.7 | GO:0097264 | self proteolysis(GO:0097264) |
1.2 | 2.5 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.2 | 4.9 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.2 | 3.6 | GO:0035106 | operant conditioning(GO:0035106) |
1.2 | 1.2 | GO:0060594 | mammary gland specification(GO:0060594) |
1.2 | 4.8 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.2 | 3.6 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
1.2 | 3.6 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.2 | 4.7 | GO:0007412 | axon target recognition(GO:0007412) |
1.2 | 5.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.2 | 1.2 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.1 | 2.3 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.1 | 61.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.1 | 9.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.1 | 3.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.1 | 10.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.0 | 17.6 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.0 | 2.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.0 | 2.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
1.0 | 5.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.0 | 3.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.0 | 4.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.0 | 2.9 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
1.0 | 2.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.0 | 1.9 | GO:0021586 | pons maturation(GO:0021586) |
1.0 | 3.8 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.9 | 3.8 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.9 | 2.8 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.9 | 3.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.9 | 2.8 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.9 | 2.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.9 | 2.7 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.9 | 3.6 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.9 | 10.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.9 | 2.7 | GO:0072017 | distal tubule development(GO:0072017) |
0.9 | 4.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.9 | 2.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.9 | 4.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.9 | 3.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.8 | 2.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.8 | 1.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.8 | 1.7 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.8 | 5.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.8 | 8.2 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.8 | 3.3 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.8 | 5.7 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.8 | 2.4 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.8 | 0.8 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.8 | 1.6 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.8 | 5.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.8 | 5.4 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.8 | 1.5 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.8 | 4.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.8 | 3.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.8 | 0.8 | GO:0008038 | neuron recognition(GO:0008038) |
0.8 | 3.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.8 | 0.8 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.8 | 0.8 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.7 | 1.5 | GO:2000822 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.7 | 2.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.7 | 6.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.7 | 1.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.7 | 3.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.7 | 3.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.7 | 6.9 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.7 | 1.4 | GO:0021626 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.7 | 2.0 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.7 | 10.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.7 | 2.7 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.7 | 2.0 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.7 | 1.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.7 | 10.1 | GO:0035640 | exploration behavior(GO:0035640) |
0.7 | 2.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 0.7 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.7 | 2.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.7 | 1.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.6 | 9.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.6 | 1.9 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.6 | 7.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.6 | 2.5 | GO:0050955 | thermoception(GO:0050955) |
0.6 | 2.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.6 | 13.8 | GO:0007616 | long-term memory(GO:0007616) |
0.6 | 2.5 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.6 | 1.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.6 | 1.8 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.6 | 7.3 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.6 | 6.1 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.6 | 0.6 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.6 | 1.2 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.6 | 4.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 0.6 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.6 | 2.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.6 | 2.4 | GO:0035989 | tendon development(GO:0035989) |
0.6 | 1.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.6 | 5.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.6 | 1.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.6 | 4.6 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.6 | 1.2 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.6 | 2.9 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.6 | 1.2 | GO:0001975 | response to amphetamine(GO:0001975) |
0.6 | 5.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 0.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.6 | 4.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.6 | 3.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.6 | 0.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.6 | 1.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.6 | 42.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 1.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.6 | 2.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 2.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.5 | 1.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.5 | 3.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.5 | 1.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 15.4 | GO:0021766 | hippocampus development(GO:0021766) |
0.5 | 2.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.5 | 0.5 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.5 | 1.0 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 3.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.5 | 1.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.5 | 1.0 | GO:0030432 | peristalsis(GO:0030432) |
0.5 | 1.0 | GO:0046959 | habituation(GO:0046959) |
0.5 | 1.0 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.5 | 2.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 1.5 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.5 | 33.9 | GO:0007612 | learning(GO:0007612) |
0.5 | 1.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.5 | 4.9 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.5 | 6.9 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 1.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.5 | 1.5 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.5 | 4.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.5 | 1.5 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.5 | 0.5 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.5 | 1.9 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.5 | 6.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.5 | 2.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.5 | 0.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.5 | 3.8 | GO:0070977 | bone maturation(GO:0070977) |
0.5 | 0.5 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.5 | 0.5 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.5 | 2.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.5 | 5.5 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.5 | 0.9 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.5 | 0.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 0.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.4 | 1.3 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.4 | 4.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 0.9 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.4 | 1.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.4 | 0.4 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.4 | 10.5 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.4 | 13.9 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.4 | 1.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 0.4 | GO:0017085 | response to insecticide(GO:0017085) |
0.4 | 3.9 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.4 | 1.3 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 0.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.4 | 1.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.4 | 3.8 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.4 | 1.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 0.8 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.4 | 1.2 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.4 | 1.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 1.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 10.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.4 | 0.8 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.4 | 2.4 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.4 | 0.8 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.4 | 1.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 1.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 0.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 1.6 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 1.6 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.4 | 0.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 2.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 1.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 0.8 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.4 | 0.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 7.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 1.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.4 | 1.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.4 | 1.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.4 | 0.4 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 0.4 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.4 | 1.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 1.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 0.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.4 | 1.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 0.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 1.8 | GO:0015824 | proline transport(GO:0015824) |
0.4 | 1.4 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.4 | 0.7 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.4 | 1.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.4 | 10.9 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 1.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 3.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 1.8 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.3 | 1.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 1.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 0.7 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 0.7 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.3 | 1.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 1.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 1.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 1.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.3 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.3 | 9.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 0.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.3 | 0.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.3 | 0.7 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.3 | 0.7 | GO:0060686 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.3 | 1.0 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.3 | 0.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.3 | 2.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 1.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.3 | 0.6 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 1.6 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.3 | 1.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 0.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 0.9 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 0.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.3 | 2.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 0.6 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.3 | 1.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 1.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.3 | 0.9 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.3 | 5.9 | GO:0007416 | synapse assembly(GO:0007416) |
0.3 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 1.6 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 1.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.3 | 1.5 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.3 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 0.9 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.3 | 1.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.3 | 0.3 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.3 | 0.6 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 1.2 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.3 | 0.3 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.3 | 4.7 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.3 | 0.9 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 0.3 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.3 | 1.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 0.6 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.3 | 0.3 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.3 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.3 | 0.3 | GO:2000049 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 0.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 0.9 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 1.4 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 4.3 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.3 | 0.3 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.3 | 0.6 | GO:1902688 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.3 | 0.8 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 0.8 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.3 | 0.3 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.3 | 2.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.3 | 0.3 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.3 | 1.6 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.3 | 2.2 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 0.5 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.3 | 0.8 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 0.5 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 0.3 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.3 | 0.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 0.5 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 1.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 0.8 | GO:0045714 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.3 | 0.8 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 0.3 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.3 | 0.5 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 6.5 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.3 | 16.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 2.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 0.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 0.3 | GO:0048243 | regulation of norepinephrine secretion(GO:0014061) norepinephrine secretion(GO:0048243) |
0.3 | 18.0 | GO:0007411 | axon guidance(GO:0007411) |
0.3 | 2.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.3 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.3 | 0.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.3 | 6.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 0.8 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 0.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 2.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.2 | 0.7 | GO:0070305 | response to cGMP(GO:0070305) |
0.2 | 0.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 1.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 1.2 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.2 | 0.5 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 1.0 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.2 | 6.7 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.2 | GO:0021546 | rhombomere development(GO:0021546) |
0.2 | 0.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.7 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 6.2 | GO:0050808 | synapse organization(GO:0050808) |
0.2 | 0.5 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 1.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.7 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.2 | 1.2 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.2 | 0.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.2 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 1.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 0.5 | GO:0032762 | mast cell cytokine production(GO:0032762) regulation of mast cell cytokine production(GO:0032763) |
0.2 | 0.2 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.2 | 0.7 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 2.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.2 | 1.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.7 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 2.5 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.9 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 0.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.7 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 3.4 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.7 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 2.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 9.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.2 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 1.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.6 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.2 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.9 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 0.2 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.2 | 1.7 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.2 | 0.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.2 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 0.6 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.8 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.6 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.2 | 0.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.2 | 17.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.2 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 0.6 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.2 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 0.6 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 1.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 0.2 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.2 | 1.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 1.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 1.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.6 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 0.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.4 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.2 | 5.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 1.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.6 | GO:1903044 | protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
0.2 | 2.1 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.2 | 4.9 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 0.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.2 | 0.4 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 10.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.2 | 1.5 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.2 | 1.1 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 0.4 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 0.4 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.8 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 0.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.9 | GO:0031650 | regulation of heat generation(GO:0031650) |
0.2 | 0.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 0.6 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 2.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.2 | 0.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.5 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 1.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.2 | 0.7 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.2 | 1.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.2 | 1.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 0.5 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.2 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 1.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.7 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.3 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.2 | 1.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.2 | 0.2 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.2 | 0.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 0.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.2 | 0.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.3 | GO:0043584 | nose development(GO:0043584) |
0.2 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 0.2 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.2 | 1.0 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.2 | 1.1 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 0.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.5 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 1.8 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 1.3 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 0.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.3 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.2 | 0.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 1.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.2 | 0.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 1.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 0.3 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 0.3 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 0.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.3 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.1 | 0.3 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 1.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 1.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.3 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.3 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.3 | GO:0043482 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 1.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 1.1 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.3 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of exocyst localization(GO:0060178) |
0.1 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.7 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 1.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.1 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.1 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 1.7 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.1 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.8 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.6 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.1 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 4.1 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.1 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 1.3 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 3.0 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.1 | 1.0 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.6 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 1.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 2.0 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 0.7 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 2.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.2 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 3.1 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 3.5 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.1 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.5 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 2.2 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.1 | 0.3 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 3.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.9 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 1.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 1.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.4 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 1.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 6.6 | GO:0007409 | axonogenesis(GO:0007409) |
0.1 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 2.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0060129 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.2 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.5 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.1 | 0.4 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.3 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 1.0 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.1 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.1 | 0.9 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 1.0 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.5 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.1 | 0.3 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.3 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 2.1 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 1.6 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.8 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.2 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 0.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.3 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.7 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 3.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.4 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.3 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.1 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.1 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.7 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 0.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.4 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.1 | 0.1 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.1 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 1.3 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 2.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.3 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.1 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 2.3 | GO:0007626 | locomotory behavior(GO:0007626) |
0.1 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.2 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.1 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.1 | 0.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 1.4 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.2 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.4 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 0.1 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.2 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.5 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.1 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.0 | 0.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.0 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.2 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.1 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.1 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.1 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.2 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.1 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 0.1 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.0 | 0.8 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.1 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.0 | 0.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.2 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.2 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.0 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 2.6 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.3 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.0 | 0.0 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.0 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.0 | 0.1 | GO:1903432 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.0 | 0.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.0 | 0.1 | GO:0050905 | neuromuscular process(GO:0050905) |
0.0 | 0.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.2 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 1.2 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.0 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.0 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.0 | 0.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.2 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.0 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.0 | GO:2000650 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.5 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.3 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.4 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.2 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.0 | 0.0 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
0.0 | 0.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.0 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.0 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.0 | 0.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.0 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.0 | 0.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.0 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.0 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.0 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.0 | 0.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.2 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.0 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 19.4 | GO:0043083 | synaptic cleft(GO:0043083) |
2.3 | 11.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
2.2 | 22.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.1 | 6.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.8 | 34.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.7 | 85.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.7 | 10.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.7 | 13.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.6 | 7.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.5 | 9.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.5 | 12.2 | GO:0005883 | neurofilament(GO:0005883) |
1.4 | 14.4 | GO:0030673 | axolemma(GO:0030673) |
1.4 | 4.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.3 | 15.1 | GO:0043194 | axon initial segment(GO:0043194) |
1.2 | 1.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.1 | 29.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.0 | 6.0 | GO:0032584 | growth cone membrane(GO:0032584) |
1.0 | 23.4 | GO:0044295 | axonal growth cone(GO:0044295) |
1.0 | 1.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.9 | 10.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.9 | 0.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.9 | 11.9 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.8 | 9.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.8 | 34.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.8 | 4.1 | GO:0097433 | dense body(GO:0097433) |
0.8 | 5.7 | GO:0071437 | invadopodium(GO:0071437) |
0.8 | 11.2 | GO:0031045 | dense core granule(GO:0031045) |
0.8 | 5.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.8 | 22.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.8 | 106.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.8 | 3.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.8 | 1.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.8 | 1.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.7 | 1.5 | GO:0097441 | basilar dendrite(GO:0097441) |
0.7 | 5.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.7 | 2.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.7 | 3.4 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.7 | 2.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.7 | 2.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.6 | 1.9 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 2.6 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.6 | 14.4 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.6 | 5.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.6 | 1.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.6 | 1.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.6 | 1.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 1.7 | GO:0032590 | dendrite membrane(GO:0032590) |
0.6 | 1.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.5 | 7.6 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 3.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 43.1 | GO:0030426 | growth cone(GO:0030426) |
0.5 | 27.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.5 | 3.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.5 | 6.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.5 | 1.8 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.4 | 1.8 | GO:1990745 | EARP complex(GO:1990745) |
0.4 | 2.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 4.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 0.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.4 | 27.8 | GO:0043204 | perikaryon(GO:0043204) |
0.4 | 2.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 2.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.4 | 2.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 2.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.4 | 1.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 1.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.4 | 0.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.3 | 1.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 1.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 2.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 15.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 2.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 0.6 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 0.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 42.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 0.6 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 0.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 1.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 1.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 1.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 3.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 14.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.3 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 3.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 1.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 1.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 0.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 7.6 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 4.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 13.6 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.2 | 3.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 0.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 32.0 | GO:0045202 | synapse(GO:0045202) |
0.2 | 12.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 0.6 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 2.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 1.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 1.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 0.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 3.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 2.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 1.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 1.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 1.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 1.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.7 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 2.4 | GO:0043679 | axon terminus(GO:0043679) |
0.2 | 5.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 1.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 36.4 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 21.3 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 0.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.5 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 1.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 2.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.2 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 1.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 1.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.7 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 1.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.4 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 1.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.2 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 1.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.2 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 1.1 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 2.4 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.6 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 0.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 2.4 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 1.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.7 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 5.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.5 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.6 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.2 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.5 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.7 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.0 | GO:1903349 | omegasome membrane(GO:1903349) |
0.0 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 1.0 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.7 | GO:0097458 | neuron part(GO:0097458) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.0 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.0 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.0 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 11.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
3.7 | 11.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.4 | 10.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.2 | 12.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
3.1 | 15.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.9 | 5.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.8 | 11.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.5 | 7.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.4 | 9.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.2 | 8.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.0 | 10.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.0 | 16.0 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
2.0 | 5.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.9 | 9.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.9 | 17.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.8 | 5.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.7 | 5.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.6 | 9.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.5 | 16.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.4 | 4.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.3 | 4.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.3 | 5.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.2 | 10.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.2 | 12.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.1 | 11.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
1.1 | 28.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.1 | 6.7 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.1 | 3.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.1 | 13.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.1 | 5.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.1 | 20.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.1 | 2.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.0 | 4.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.0 | 3.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.0 | 9.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.0 | 2.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.0 | 6.7 | GO:0003680 | AT DNA binding(GO:0003680) |
1.0 | 1.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.9 | 3.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.9 | 3.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.9 | 2.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.9 | 5.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.9 | 2.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.9 | 4.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.9 | 6.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.8 | 11.8 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.8 | 6.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.8 | 2.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.8 | 17.6 | GO:0044688 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.8 | 2.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.8 | 18.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.7 | 6.7 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.7 | 2.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.7 | 2.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.7 | 14.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.7 | 2.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.7 | 3.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.7 | 3.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 9.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.6 | 1.9 | GO:0018556 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.6 | 3.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.6 | 4.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 1.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 1.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.6 | 15.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.6 | 11.0 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.6 | 3.0 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.6 | 7.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 1.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.6 | 1.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 0.6 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.6 | 8.5 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.6 | 13.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.6 | 0.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.6 | 2.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.6 | 2.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 4.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.6 | 5.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.6 | 2.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.6 | 2.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.5 | 17.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.5 | 1.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.5 | 0.5 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.5 | 2.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.5 | 1.6 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 9.4 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.5 | 1.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.5 | 3.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 2.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.5 | 1.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.5 | 4.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.5 | 1.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.5 | 0.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.5 | 0.9 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.5 | 2.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 0.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.5 | 3.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.5 | 5.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.4 | 5.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 0.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 7.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.4 | 2.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 2.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 4.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.4 | 12.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.4 | 1.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 1.7 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.4 | 4.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 0.8 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.4 | 8.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 2.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 1.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 5.9 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.4 | 1.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 8.1 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.4 | 4.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 10.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 4.2 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 1.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 1.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 6.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 9.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 3.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.4 | 0.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 0.7 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.4 | 1.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 1.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 1.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 1.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 4.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.3 | 1.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.0 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 3.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 2.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 1.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 6.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 1.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 3.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 1.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 0.6 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 1.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 0.9 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 0.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 6.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.3 | 1.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 8.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 1.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 6.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 0.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 1.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 5.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 1.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 1.8 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.3 | 4.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 15.6 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.3 | 1.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.3 | 1.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 1.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 0.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 0.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 1.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 7.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 1.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 4.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 6.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 5.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 6.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 6.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.3 | 1.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 0.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 5.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 1.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 4.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 1.2 | GO:0050544 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.2 | 0.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 4.1 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 0.7 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 2.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 2.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 0.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 2.0 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 0.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 0.7 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.2 | 16.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 4.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.2 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.2 | 2.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 2.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 1.0 | GO:0050664 | superoxide-generating NADPH oxidase activity(GO:0016175) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.2 | 2.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.8 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.2 | 3.0 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 3.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 5.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 5.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 0.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.7 | GO:0016775 | protein histidine kinase activity(GO:0004673) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.2 | 2.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 3.7 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 2.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 1.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 0.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 1.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.5 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 2.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 1.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 1.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 1.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 0.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 1.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 1.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 1.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 0.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 2.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 28.5 | GO:0015631 | tubulin binding(GO:0015631) |
0.2 | 5.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.2 | 0.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 1.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.5 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 2.7 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 1.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 1.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 2.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.1 | GO:0001226 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.3 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.4 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 2.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.4 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.8 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 3.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.6 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.7 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.2 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.5 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 1.0 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 2.3 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 3.1 | GO:0052693 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 1.3 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.6 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 2.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 3.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 1.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.4 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.5 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.2 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.2 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.4 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 13.2 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 1.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 7.4 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 0.6 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.2 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.3 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 1.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 1.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.4 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 1.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 1.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 2.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 2.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.7 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 22.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.7 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 1.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.0 | 0.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 3.1 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.1 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 1.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.2 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.0 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.2 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.0 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 13.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 9.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 16.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.6 | 15.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 14.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 16.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 1.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 9.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 3.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 2.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 18.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 9.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 8.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 3.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 5.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 14.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 11.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.3 | 6.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 0.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 3.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 7.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 6.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 2.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 1.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 3.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 1.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 3.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.9 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 2.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 2.8 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
1.8 | 26.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.6 | 19.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.4 | 20.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.3 | 13.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.2 | 13.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.2 | 21.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.2 | 30.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.2 | 20.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.1 | 3.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.1 | 11.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.0 | 1.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.9 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.9 | 13.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.9 | 0.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.9 | 18.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.9 | 1.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.8 | 6.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.8 | 17.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.7 | 6.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.7 | 7.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.7 | 19.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.7 | 9.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.6 | 8.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.6 | 1.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.5 | 21.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.5 | 7.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.5 | 9.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 6.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.5 | 5.6 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.5 | 8.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.4 | 0.4 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.4 | 5.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 8.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 4.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 2.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.4 | 5.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 4.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 0.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.3 | 6.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 1.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 0.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 4.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 2.5 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.3 | 0.6 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.3 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 4.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 1.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 5.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 5.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 2.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 3.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 2.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 4.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 9.0 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 7.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.2 | 3.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 1.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 0.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 3.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 2.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 8.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 1.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 20.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 3.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 2.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 1.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.1 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.1 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 3.1 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 1.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 2.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 2.4 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 0.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 1.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |